Retatrutide vs Tirzepatide

The Dose Guy’s verdict

Oct 27, 2026
13 sources

Pick by how much you have to lose. A big cut belongs to retatrutide; the last few kilos, or a wish for the most proven option, belong to tirzepatide. Retatrutide is the stronger drug, with years of community mileage on it, and runs a little hotter for it; tirzepatide is the smoother ride, with an approval and years of outcome data behind it. Never run the two together. If you cut on retatrutide, tirzepatide is a good place to land once the big weight is gone.

Which would I take?Reta for the big cut, tirz once you're lean.

How they differ

The difference that matters is how hard each one pulls, and what the extra pull costs. Tirzepatide, the drug in Mounjaro and Zepbound, works two receptors, GLP-1 and GIP: meals sit longer, the chatter about food fades, and smaller plates stop feeling like a sacrifice. Retatrutide adds a third, glucagon, which spends energy on top of cutting intake. That arm is why it out-cuts tirzepatide on a heavy frame, and why you feel it more: a higher resting heart rate, running warm at night, and more gut complaint near the top of its range.

That decides who each one is for. With a lot to lose, retatrutide’s extra pull is the point. On a lean frame it is more than you need: hunger can go so quiet that eating enough protein becomes the daily chore, and muscle pays for it. That is why athletes and lifters dieting down the last few kilos belong on tirzepatide, where the appetite control is firm but you can still eat to train.

Day to day, the rhythm is the same. Both sit in your blood for most of a week, so both are one pin on one day, and switching between them never means relearning a schedule. If semaglutide is the third name in your search, both of these out-lose it; it is the pick when a pharmacy route or caution matters more than maximum effect.

What the research shows

Nobody has run these two against each other, so this is two trial programs side by side, not a race:

No head-to-head trial of retatrutide against tirzepatide exists, and retatrutide has no published cardiovascular or kidney outcome results yet.as of Aug 2026

Retatrutide 12 mg: 24.2% mean weight loss at 48 weeks, versus 2.1% on placebo.NEJM 2023 · phase 2 · n=338

Tirzepatide 15 mg in SURMOUNT-1: 20.9% mean weight loss at 72 weeks, versus 3.1% on placebo.NEJM 2022 · phase 3 · n=2539

An indirect comparison across 19 trials: retatrutide and the dual agonists matched at 11.0 kg mean loss, above GLP-1 agonists at 9.0 kg, but retatrutide had the highest odds of reaching at least 15% loss, an odds ratio of 54.6, and the highest adverse-event risk.Obesity 2025 · network meta-analysis · n=29506

Across 262 obesity-drug trials, tirzepatide’s one-year weight loss rests on moderate to high certainty evidence; retatrutide’s rests on very low to low certainty.BMJ 2026 · network meta-analysis · n=99791

Read together with the meta-analyses, they say the same thing my verdict does: retatrutide’s edge shows at the deep end of a cut, and tirzepatide owns the certainty.

How people run them

Both get the same treatment: one weekly sub-q pin, dosed to your hunger. Start low, hold while appetite stays quiet, and raise only when real hunger returns, giving each change about a month. Holding a low dose that works is winning on either one. What differs is the scale. A retatrutide milligram hits harder than a tirzepatide milligram, so never carry a number from one to the other.

Switching from tirzepatide to retatrutide, take the first retatrutide dose on the day your next tirzepatide shot was due. No washout, no overlap. Start around 2 mg even if you were deep into tirzepatide: your gut knows incretins, the gut-hormone mimics both drugs are, but the glucagon arm’s heat and heart-rate bump arrive fresh. You will likely climb faster than a first-timer, so let hunger set the pace. Going the other way, usually once the big cut is done, swap on the same day and start tirzepatide at 2.5 or 5 mg.

Do not stack them. Two incretins on one gut piles on the nausea for no proven extra loss. If the appetite grip fades on either one after months, the add-on is a small weekly dose of cagrilintide, a different hunger circuit. On both, skip the alcohol, because drinks sit badly on a slowed gut, and keep protein high and keep lifting the whole way down.

Retatrutide1–2 mg/wk startPlenty of people hold in the low single digits; 12 mg is the trial ceiling, not a goal.

Tirzepatide2.5 mg/wk startMost people find their dose in the lower half of the steps to 15 mg.

Tirz to reta~2 mg, next slotStart low anyway; the glucagon arm is new to your body.

Reta to tirz2.5–5 mg, next slotThe usual move once the cut is done and you want a gentler ride.

Add-on+ cagrilintideFor a fading appetite grip on either one.

Side effects, side by side

Same incretin gut profile on both; retatrutide adds heat on top:

commonNausea, constipation, diarrhea, and the odd vomiting day, clustered around dose raises on both. Retatrutide carries more of it near its top doses; slower raises fix most of it.

monitorResting heart rate climbs on retatrutide, the glucagon arm’s tell; it rose early and eased with time. Check yours before you start and now and then. Tirzepatide nudges it less.

anecdotalNight sweats and running warm on retatrutide, reported widely. Tiredness in the first few weeks on tirzepatide, usually gone soon after.

anecdotalHair shedding on either, tied to how fast the weight comes off and how little protein goes in. The faster cut sees more of it; eat your protein.

monitorGallbladder trouble at a low rate on both, likelier the faster you lose. Sharp right-sided belly pain gets checked.

monitorBoth carry the class’s small pancreatitis signal. Severe upper-belly pain that does not pass is a stop-and-get-checked, not a push-through.